• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[The use of agonist analogues of luteinizing hormone--releasing hormone in the treatment of prostatic carcinoma].

作者信息

Gez E, Ben-Yosef R, Libson E, Biran S

出版信息

Harefuah. 1987 Mar 1;112(5):239-41.

PMID:3301586
Abstract
摘要

相似文献

1
[The use of agonist analogues of luteinizing hormone--releasing hormone in the treatment of prostatic carcinoma].
Harefuah. 1987 Mar 1;112(5):239-41.
2
Luteinizing hormone-releasing hormone analogues and hormone ablation for prostate cancer: state of the art.促黄体生成素释放激素类似物与激素消融治疗前列腺癌：现状
BJU Int. 2007 Jul;100 Suppl 2:2-4. doi: 10.1111/j.1464-410X.2007.06942.x.
3
A comparative study of a long acting luteinizing hormone releasing hormone agonist (Decapeptyl) and orchiectomy in the treatment of advanced prostatic cancer. Preliminary report.长效促黄体生成素释放激素激动剂（曲普瑞林）与睾丸切除术治疗晚期前列腺癌的比较研究。初步报告。
Acta Urol Belg. 1986;54(2):221-9.
4
[Luteinizing hormone-releasing hormone agonists for treatment of prostatic cancer].用于治疗前列腺癌的促黄体生成素释放激素激动剂
Harefuah. 1990 Apr 15;118(8):483-6.
5
Uncommon course of carcinoma of the prostate after radical prostatectomy and luteinizing hormone-releasing hormone analogue therapy.前列腺癌根治术及促黄体生成素释放激素类似物治疗后的罕见病程
J Urol. 1998 Oct;160(4):1432-3.
6
Gonadotrophin releasing hormone analogues for advanced prostate cancer.用于晚期前列腺癌的促性腺激素释放激素类似物
Drug Ther Bull. 1992 Aug 17;30(17):65-7.
7
LHRH analogues in the treatment of prostatic cancer. Introduction.促性腺激素释放激素类似物在前列腺癌治疗中的应用。引言。
Br J Clin Pract Suppl. 1985 Mar;37:2-3, 14-5.
8
[Does the pharmacological class effect between the different luteinizing hormone releasing hormone analogues used in the treatment of prostate cancer have to be assumed?].[是否必须假定用于治疗前列腺癌的不同促黄体生成素释放激素类似物之间存在药理学类别效应？]
Actas Urol Esp. 2010 Oct;34(9):749-57.
9
[Introduction: recent progress in therapy of prostatic carcinoma and other hormone dependent pathology with the use of agonistic analogs of LHRH].
Drugs Exp Clin Res. 1990;16 Suppl:1-2.
10
Results of a Dutch Phase II trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer.
Prog Clin Biol Res. 1985;185A:251-70.